{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:08:08Z","timestamp":1790456888203,"version":"4.1.0"},"reference-count":148,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.bbadis.2018.11.017","type":"journal-article","created":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T11:16:08Z","timestamp":1543058168000},"page":"1992-2000","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["The role of posttranslational modifications of \u03b1-synuclein and LRRK2 in Parkinson's disease: Potential contributions of environmental factors"],"prefix":"10.1016","volume":"1865","author":[{"given":"Edward","family":"Pajarillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha","family":"Rizor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayden","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Aschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunsook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bbadis.2018.11.017_bb0005","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s12035-012-8369-3","article-title":"The central theme of Parkinson's disease: alpha-synuclein","volume":"47","author":"Ozansoy","year":"2013","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.bbadis.2018.11.017_bb0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1750-1326-6-6","article-title":"Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson's disease?","volume":"6","author":"Greggio","year":"2011","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.bbadis.2018.11.017_bb0015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2217\/fnl.12.2","article-title":"Alpha-synuclein, LRRK2 and their interplay in Parkinson's disease","volume":"7","author":"Liu","year":"2012","journal-title":"Future Neurol."},{"issue":"Pt B","key":"10.1016\/j.bbadis.2018.11.017_bb0020","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.brainres.2015.06.002","article-title":"Post-translational modification of alpha-synuclein in Parkinson's disease","volume":"1628","author":"Barrett","year":"2015","journal-title":"Brain Res."},{"issue":"164","key":"10.1016\/j.bbadis.2018.11.017_bb0025","doi-asserted-by":"crossref","first-page":"164ra161","DOI":"10.1126\/scitranslmed.3004485","article-title":"Ser1292 autophosphorylation is an indicator of LRRK2 kinase activity and contributes to the cellular effects of PD mutations","volume":"4","author":"Sheng","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.bbadis.2018.11.017_bb0030","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/mds.26892","article-title":"LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies","volume":"32","author":"Dzamko","year":"2017","journal-title":"Mov. Disord."},{"issue":"1\u20133","key":"10.1016\/j.bbadis.2018.11.017_bb0035","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.febslet.2004.07.046","article-title":"Phosphorylated alpha-synuclein in normal mouse brain","volume":"572","author":"Hirai","year":"2004","journal-title":"FEBS Lett."},{"issue":"Pt B","key":"10.1016\/j.bbadis.2018.11.017_bb0040","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jchemneu.2016.01.007","article-title":"LRRK2 G2019S transgenic mice display increased susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-mediated neurotoxicity","volume":"76","author":"Karuppagounder","year":"2016","journal-title":"J. Chem. Neuroanat."},{"issue":"7","key":"10.1016\/j.bbadis.2018.11.017_bb0045","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1021\/ac051978n","article-title":"Identification of rotenone-induced modifications in alpha-synuclein using affinity pull-down and tandem mass spectrometry","volume":"78","author":"Mirzaei","year":"2006","journal-title":"Anal. Chem."},{"issue":"9","key":"10.1016\/j.bbadis.2018.11.017_bb0050","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1212\/WNL.44.9.1583","article-title":"Manganism and idiopathic parkinsonism: similarities and differences","volume":"44","author":"Calne","year":"1994","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.bbadis.2018.11.017_bb0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.molbrainres.2004.11.007","article-title":"Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures","volume":"134","author":"Testa","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"1","key":"10.1016\/j.bbadis.2018.11.017_bb0060","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bbrc.2018.02.007","article-title":"Role of LRRK2 in manganese-induced neuroinflammation and microglial autophagy","volume":"498","author":"Chen","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.bbadis.2018.11.017_bb0065","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/hmg\/6.10.1687","article-title":"Genetics of Parkinson's disease","volume":"6","author":"Nussbaum","year":"1997","journal-title":"Hum. Mol. Genet."},{"issue":"5321","key":"10.1016\/j.bbadis.2018.11.017_bb0070","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.bbadis.2018.11.017_bb0075","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3233\/JAD-2004-6412","article-title":"Demonstration of a role for alpha-synuclein as a functional microtubule-associated protein","volume":"6","author":"Alim","year":"2004","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2018.11.017_bb0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/1735-1995.181989","article-title":"Alpha-synuclein structure, functions, and interactions","volume":"21","author":"Emamzadeh","year":"2016","journal-title":"J. Res. Med. Sci."},{"issue":"1","key":"10.1016\/j.bbadis.2018.11.017_bb0085","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s40478-016-0402-8","article-title":"The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation","volume":"4","author":"Lazaro","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbadis.2018.11.017_bb0090","first-page":"1720621","article-title":"Alpha-synuclein in Parkinson's disease: from pathogenetic dysfunction to potential clinical application","volume":"2016","author":"Xu","year":"2016","journal-title":"Park. Dis."},{"issue":"10","key":"10.1016\/j.bbadis.2018.11.017_bb0095","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/j.bpj.2017.08.027","article-title":"Modification of C terminus provides new insights into the mechanism of alpha-synuclein aggregation","volume":"113","author":"Afitska","year":"2017","journal-title":"Biophys. J."},{"issue":"3","key":"10.1016\/j.bbadis.2018.11.017_bb0100","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-2990.2007.00888.x","article-title":"LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinson's disease","volume":"34","author":"Alegre-Abarrategui","year":"2008","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"26","key":"10.1016\/j.bbadis.2018.11.017_bb0105","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1021\/bi100157u","article-title":"Membrane localization of LRRK2 is associated with increased formation of the highly active LRRK2 dimer and changes in its phosphorylation","volume":"49","author":"Berger","year":"2010","journal-title":"Biochemistry"},{"issue":"11","key":"10.1016\/j.bbadis.2018.11.017_bb0110","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1002\/cne.23583","article-title":"Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents","volume":"522","author":"West","year":"2014","journal-title":"J. Comp. Neurol."},{"issue":"47","key":"10.1016\/j.bbadis.2018.11.017_bb0115","doi-asserted-by":"crossref","first-page":"11366","DOI":"10.1523\/JNEUROSCI.0964-17.2017","article-title":"Parkinson's disease-associated LRRK2 hyperactive kinase mutant disrupts synaptic vesicle trafficking in ventral midbrain neurons","volume":"37","author":"Pan","year":"2017","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bbadis.2018.11.017_bb0120","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M110.001172","article-title":"A QUICK screen for Lrrk2 interaction partners--leucine-rich repeat kinase 2 is involved in actin cytoskeleton dynamics","volume":"10","author":"Meixner","year":"2011","journal-title":"Mol. Cell. Proteomics"},{"issue":"6","key":"10.1016\/j.bbadis.2018.11.017_bb0125","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1523\/JNEUROSCI.3730-10.2011","article-title":"LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool","volume":"31","author":"Piccoli","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2018.11.017_bb0130","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/1742-2094-9-261","article-title":"LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein","volume":"9","author":"Marker","year":"2012","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"10.1016\/j.bbadis.2018.11.017_bb0135","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1523\/JNEUROSCI.5601-11.2012","article-title":"LRRK2 inhibition attenuates microglial inflammatory responses","volume":"32","author":"Moehle","year":"2012","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.bbadis.2018.11.017_bb0140","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1007\/s11033-014-3111-z","article-title":"Structural and functional in silico analysis of LRRK2 missense substitutions","volume":"41","author":"Cardona","year":"2014","journal-title":"Mol. Biol. Rep."},{"issue":"2","key":"10.1016\/j.bbadis.2018.11.017_bb0145","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ana.20731","article-title":"Lrrk2 and Lewy body disease","volume":"59","author":"Ross","year":"2006","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.bbadis.2018.11.017_bb0150","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"},{"issue":"22","key":"10.1016\/j.bbadis.2018.11.017_bb0155","doi-asserted-by":"crossref","first-page":"6455","DOI":"10.1111\/j.1742-4658.2009.07344.x","article-title":"LRRK2 in Parkinson's disease: genetic and clinical studies from patients","volume":"276","author":"Kumari","year":"2009","journal-title":"FEBS J."},{"issue":"4","key":"10.1016\/j.bbadis.2018.11.017_bb0160","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMc055540","article-title":"LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs","volume":"354","author":"Lesage","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2018.11.017_bb0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuroscience.2012.02.001","article-title":"Parkinson's disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity","volume":"208","author":"Gillardon","year":"2012","journal-title":"Neuroscience"},{"issue":"34","key":"10.1016\/j.bbadis.2018.11.017_bb0170","doi-asserted-by":"crossref","first-page":"14622","DOI":"10.1073\/pnas.0906334106","article-title":"R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice","volume":"106","author":"Tong","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bbadis.2018.11.017_bb0175","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/hmg\/ddl471","article-title":"Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity","volume":"16","author":"West","year":"2007","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.bbadis.2018.11.017_bb0180","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/bies.200900163","article-title":"Mechanisms in dominant parkinsonism: the toxic triangle of LRRK2, alpha-synuclein, and tau","volume":"32","author":"Taymans","year":"2010","journal-title":"Bioessays"},{"issue":"9","key":"10.1016\/j.bbadis.2018.11.017_bb0185","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/NEN.0b013e3181efc01c","article-title":"Leucine-rich repeat kinase 2 is associated with the endoplasmic reticulum in dopaminergic neurons and accumulates in the core of Lewy bodies in Parkinson disease","volume":"69","author":"Vitte","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"3","key":"10.1016\/j.bbadis.2018.11.017_bb0190","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1042\/BJ20100784","article-title":"Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser(910)\/Ser(935), disruption of 14-3-3 binding and altered cytoplasmic localization","volume":"430","author":"Dzamko","year":"2010","journal-title":"Biochem. J."},{"issue":"11","key":"10.1016\/j.bbadis.2018.11.017_bb0195","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1074\/mcp.M800116-MCP200","article-title":"Proteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactions","volume":"7","author":"McFarland","year":"2008","journal-title":"Mol. Cell. Proteomics"},{"issue":"4","key":"10.1016\/j.bbadis.2018.11.017_bb0200","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00109-012-0984-y","article-title":"LRRK2 interactions with alpha-synuclein in Parkinson's disease brains and in cell models","volume":"91","author":"Guerreiro","year":"2013","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"1","key":"10.1016\/j.bbadis.2018.11.017_bb0205","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12868-016-0315-2","article-title":"Leucine-rich repeat kinase 2 (LRRK2) regulates alpha-synuclein clearance in microglia","volume":"17","author":"Maekawa","year":"2016","journal-title":"BMC Neurosci."},{"issue":"28","key":"10.1016\/j.bbadis.2018.11.017_bb0210","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1523\/JNEUROSCI.3642-15.2016","article-title":"G2019S-LRRK2 expression augments alpha-synuclein sequestration into inclusions in neurons","volume":"36","author":"Volpicelli-Daley","year":"2016","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bbadis.2018.11.017_bb0215","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1038\/s41467-018-05958-z","article-title":"LRRK2 kinase regulates alpha-synuclein propagation via RAB35 phosphorylation","volume":"9","author":"Bae","year":"2018","journal-title":"Nat. Commun."},{"issue":"451","key":"10.1016\/j.bbadis.2018.11.017_bb0220","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar5429","article-title":"LRRK2 activation in idiopathic Parkinson's disease","volume":"10","author":"Di Maio","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"39","key":"10.1016\/j.bbadis.2018.11.017_bb0225","doi-asserted-by":"crossref","first-page":"E9115","DOI":"10.1073\/pnas.1812196115","article-title":"LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis","volume":"115","author":"Eguchi","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2018.11.017_bb0230","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.nbd.2017.12.005","article-title":"Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble alpha-synuclein in neurons","volume":"111","author":"Schapansky","year":"2018","journal-title":"Neurobiol. Dis."},{"issue":"9","key":"10.1016\/j.bbadis.2018.11.017_bb0235","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrm2755","article-title":"Pathways and mechanisms of endocytic recycling","volume":"10","author":"Grant","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"32","key":"10.1016\/j.bbadis.2018.11.017_bb0240","doi-asserted-by":"crossref","first-page":"19433","DOI":"10.1074\/jbc.M115.660001","article-title":"Leucine-rich repeat kinase 2 (LRRK2) pharmacological inhibition abates alpha-synuclein gene-induced neurodegeneration","volume":"290","author":"Daher","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"25","key":"10.1016\/j.bbadis.2018.11.017_bb0245","doi-asserted-by":"crossref","first-page":"9289","DOI":"10.1073\/pnas.1403215111","article-title":"Abrogation of alpha-synuclein-mediated dopaminergic neurodegeneration in LRRK2-deficient rats","volume":"111","author":"Daher","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.bbadis.2018.11.017_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024834","article-title":"Neuropathology in mice expressing mouse alpha-synuclein","volume":"6","author":"Rieker","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bbadis.2018.11.017_bb0255","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"Alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"issue":"9","key":"10.1016\/j.bbadis.2018.11.017_bb0260","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1523\/JNEUROSCI.5922-09.2010","article-title":"Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactions","volume":"30","author":"Paleologou","year":"2010","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.bbadis.2018.11.017_bb0265","first-page":"3257","article-title":"Tyrosine and serine phosphorylation of alpha-synuclein have opposing effects on neurotoxicity and soluble oligomer formation","volume":"119","author":"Chen","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.bbadis.2018.11.017_bb0270","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1074\/jbc.M109.081950","article-title":"Phosphorylation of synucleins by members of the Polo-like kinase family","volume":"285","author":"Mbefo","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.11.017_bb0275","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.50","article-title":"Increased alpha-synuclein phosphorylation and nitration in the aging primate substantia nigra","volume":"3","author":"McCormack","year":"2012","journal-title":"Cell Death Dis."},{"issue":"19","key":"10.1016\/j.bbadis.2018.11.017_bb0280","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1523\/JNEUROSCI.6513-10.2011","article-title":"Enhanced phosphatase activity attenuates alpha-synucleinopathy in a mouse model","volume":"31","author":"Lee","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2018.11.017_bb0285","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.neuroscience.2012.01.028","article-title":"Lewy-like aggregation of alpha-synuclein reduces protein phosphatase 2A activity in vitro and in vivo","volume":"207","author":"Wu","year":"2012","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.bbadis.2018.11.017_bb0290","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1007\/s11033-009-9899-2","article-title":"Molecular interaction of alpha-synuclein with tubulin influences on the polymerization of microtubule in vitro and structure of microtubule in cells","volume":"37","author":"Zhou","year":"2010","journal-title":"Mol. Biol. Rep."},{"issue":"4","key":"10.1016\/j.bbadis.2018.11.017_bb0295","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.neuroscience.2009.03.002","article-title":"Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice","volume":"160","author":"Schell","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2018.11.017_bb0300","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mcn.2014.08.002","article-title":"Linking alpha-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells","volume":"62","author":"Perfeito","year":"2014","journal-title":"Mol. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.bbadis.2018.11.017_bb0305","doi-asserted-by":"crossref","first-page":"16533","DOI":"10.1038\/s41598-017-15813-8","article-title":"Phosphorylated exogenous alpha-synuclein fibrils exacerbate pathology and induce neuronal dysfunction in mice","volume":"7","author":"Karampetsou","year":"2017","journal-title":"Sci. Rep."},{"issue":"34","key":"10.1016\/j.bbadis.2018.11.017_bb0310","doi-asserted-by":"crossref","first-page":"23179","DOI":"10.1074\/jbc.M802223200","article-title":"Serine 129 phosphorylation of alpha-synuclein induces unfolded protein response-mediated cell death","volume":"283","author":"Sugeno","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"41","key":"10.1016\/j.bbadis.2018.11.017_bb0315","doi-asserted-by":"crossref","first-page":"17004","DOI":"10.1073\/pnas.1109356108","article-title":"Ubiquitin ligase Nedd4 promotes alpha-synuclein degradation by the endosomal-lysosomal pathway","volume":"108","author":"Tofaris","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"50","key":"10.1016\/j.bbadis.2018.11.017_bb0320","doi-asserted-by":"crossref","first-page":"49071","DOI":"10.1074\/jbc.M208046200","article-title":"Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions","volume":"277","author":"Hasegawa","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbadis.2018.11.017_bb0325","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4161\/auto.5604","article-title":"Ubiquitination of alpha-synuclein and autophagy in Parkinson's disease","volume":"4","author":"Engelender","year":"2008","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.bbadis.2018.11.017_bb0330","doi-asserted-by":"crossref","first-page":"418","DOI":"10.4161\/auto.19085","article-title":"Alpha-synuclein fate: proteasome or autophagy?","volume":"8","author":"Engelender","year":"2012","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.bbadis.2018.11.017_bb0335","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00401-012-1004-6","article-title":"Protein degradation pathways in Parkinson's disease: curse or blessing","volume":"124","author":"Ebrahimi-Fakhari","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"1\u20134","key":"10.1016\/j.bbadis.2018.11.017_bb0340","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000333223","article-title":"Targeting SKP1, an ubiquitin E3 ligase component found decreased in sporadic Parkinson's disease","volume":"10","author":"Mandel","year":"2012","journal-title":"Neurodegener. Dis."},{"issue":"3","key":"10.1016\/j.bbadis.2018.11.017_bb0345","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/77060","article-title":"Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase","volume":"25","author":"Shimura","year":"2000","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.bbadis.2018.11.017_bb0350","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1353-8020(00)00015-8","article-title":"Association between a polymorphism of ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) gene and sporadic Parkinson's disease","volume":"6","author":"Zhang","year":"2000","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.bbadis.2018.11.017_bb0355","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.brainres.2012.04.018","article-title":"Alpha-synuclein mRNA and soluble alpha-synuclein protein levels in post-mortem brain from patients with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease","volume":"1459","author":"Quinn","year":"2012","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.bbadis.2018.11.017_bb0360","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1111\/j.1471-4159.2009.06293.x","article-title":"The ubiquitin ligase E6-AP promotes degradation of alpha-synuclein","volume":"110","author":"Mulherkar","year":"2009","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.bbadis.2018.11.017_bb0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014695","article-title":"Ubiquitinylation of alpha-synuclein by carboxyl terminus Hsp70-interacting protein (CHIP) is regulated by Bcl-2-associated athanogene 5 (BAG5)","volume":"6","author":"Kalia","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bbadis.2018.11.017_bb0370","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1074\/jbc.M704809200","article-title":"Monoubiquitylation of alpha-synuclein by seven in absentia homolog (SIAH) promotes its aggregation in dopaminergic cells","volume":"283","author":"Rott","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bbadis.2018.11.017_bb0375","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1523\/JNEUROSCI.0285-07.2007","article-title":"Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo","volume":"27","author":"Periquet","year":"2007","journal-title":"J. Neurosci."},{"issue":"32","key":"10.1016\/j.bbadis.2018.11.017_bb0380","doi-asserted-by":"crossref","first-page":"E4688","DOI":"10.1073\/pnas.1523597113","article-title":"Deubiquitinase Usp8 regulates alpha-synuclein clearance and modifies its toxicity in Lewy body disease","volume":"113","author":"Alexopoulou","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2018.11.017_bb0385","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41421-018-0012-7","article-title":"DNAJC5 facilitates USP19-dependent unconventional secretion of misfolded cytosolic proteins","volume":"4","author":"Xu","year":"2018","journal-title":"Cell Discov."},{"issue":"1\u20132","key":"10.1016\/j.bbadis.2018.11.017_bb0390","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.abb.2013.02.009","article-title":"Oxidation and nitration of alpha-synuclein and their implications in neurodegenerative diseases","volume":"533","author":"Chavarria","year":"2013","journal-title":"Arch. Biochem. Biophys."},{"issue":"4","key":"10.1016\/j.bbadis.2018.11.017_bb0395","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.freeradbiomed.2008.04.010","article-title":"Protein tyrosine nitration\u2013functional alteration or just a biomarker?","volume":"45","author":"Souza","year":"2008","journal-title":"Free Radic. Biol. Med."},{"issue":"Pt B","key":"10.1016\/j.bbadis.2018.11.017_bb0400","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","article-title":"Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease","volume":"109","author":"Rocha","year":"2018","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.bbadis.2018.11.017_bb0405","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0002-9440(10)64781-5","article-title":"Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies","volume":"157","author":"Duda","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"46","key":"10.1016\/j.bbadis.2018.11.017_bb0410","doi-asserted-by":"crossref","first-page":"47746","DOI":"10.1074\/jbc.M408906200","article-title":"Functional consequences of alpha-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation","volume":"279","author":"Hodara","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bbadis.2018.11.017_bb0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009956","article-title":"Nitrated alpha-synuclein induces the loss of dopaminergic neurons in the substantia nigra of rats","volume":"5","author":"Yu","year":"2010","journal-title":"PLoS One"},{"issue":"1\u20133","key":"10.1016\/j.bbadis.2018.11.017_bb0420","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0014-5793(03)00367-3","article-title":"Nitration inhibits fibrillation of human alpha-synuclein in vitro by formation of soluble oligomers","volume":"542","author":"Yamin","year":"2003","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.bbadis.2018.11.017_bb0425","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1073\/pnas.0406976102","article-title":"Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations","volume":"102","author":"Li","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5456","key":"10.1016\/j.bbadis.2018.11.017_bb0430","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","article-title":"Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders","volume":"287","author":"Masliah","year":"2000","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.bbadis.2018.11.017_bb0435","doi-asserted-by":"crossref","first-page":"7818","DOI":"10.1021\/bi047846q","article-title":"Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein","volume":"44","author":"Mishizen-Eberz","year":"2005","journal-title":"Biochemistry"},{"issue":"34","key":"10.1016\/j.bbadis.2018.11.017_bb0440","doi-asserted-by":"crossref","first-page":"9587","DOI":"10.1073\/pnas.1610099113","article-title":"Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein alpha-synuclein","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.bbadis.2018.11.017_bb0445","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","article-title":"Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein","volume":"34","author":"Giasson","year":"2002","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.bbadis.2018.11.017_bb0450","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1073\/pnas.97.9.4897","article-title":"Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation","volume":"97","author":"Serpell","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"28","key":"10.1016\/j.bbadis.2018.11.017_bb0455","doi-asserted-by":"crossref","first-page":"9441","DOI":"10.1523\/JNEUROSCI.5314-13.2014","article-title":"Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models","volume":"34","author":"Games","year":"2014","journal-title":"J. Neurosci."},{"issue":"28","key":"10.1016\/j.bbadis.2018.11.017_bb0460","doi-asserted-by":"crossref","first-page":"8530","DOI":"10.1021\/bi027363r","article-title":"Role of alpha-synuclein carboxy-terminus on fibril formation in vitro","volume":"42","author":"Murray","year":"2003","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.bbadis.2018.11.017_bb0465","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1083\/jcb.201010117","article-title":"Sumoylation inhibits alpha-synuclein aggregation and toxicity","volume":"194","author":"Krumova","year":"2011","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2018.11.017_bb0470","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-1-59745-566-4_20","article-title":"SUMO fusion technology for enhanced protein production in prokaryotic and eukaryotic expression systems","volume":"497","author":"Panavas","year":"2009","journal-title":"Methods Mol. Biol."},{"issue":"50","key":"10.1016\/j.bbadis.2018.11.017_bb0475","doi-asserted-by":"crossref","first-page":"13176","DOI":"10.1073\/pnas.1704351114","article-title":"SUMOylation and ubiquitination reciprocally regulate alpha-synuclein degradation and pathological aggregation","volume":"114","author":"Rott","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.bbadis.2018.11.017_bb0480","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103727","article-title":"N-alpha-acetylation of alpha-synuclein increases its helical folding propensity, GM1 binding specificity and resistance to aggregation","volume":"9","author":"Bartels","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.bbadis.2018.11.017_bb0485","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1021\/acschemneuro.7b00250","article-title":"N-terminal acetylation preserves alpha-synuclein from oligomerization by blocking intermolecular hydrogen bonds","volume":"8","author":"Bu","year":"2017","journal-title":"ACS Chem. Neurosci."},{"issue":"40","key":"10.1016\/j.bbadis.2018.11.017_bb0490","doi-asserted-by":"crossref","first-page":"21110","DOI":"10.1074\/jbc.M116.726612","article-title":"The impact of N-terminal acetylation of alpha-synuclein on phospholipid membrane binding and fibril structure","volume":"291","author":"Iyer","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bbadis.2018.11.017_bb0495","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1177\/1073858418756309","article-title":"LRRK2 phosphorylation: behind the scenes","volume":"24","author":"De Wit","year":"2018","journal-title":"Neuroscientist"},{"key":"10.1016\/j.bbadis.2018.11.017_bb0500","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-3-319-49969-7_3","article-title":"LRRK2 phosphorylation","volume":"14","author":"Nichols","year":"2017","journal-title":"Adv. Neurobiol."},{"issue":"3","key":"10.1016\/j.bbadis.2018.11.017_bb0505","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/BJ20100483","article-title":"14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization","volume":"430","author":"Nichols","year":"2010","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.bbadis.2018.11.017_bb0510","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1042\/BJ20141305","article-title":"LRRK2 dephosphorylation increases its ubiquitination","volume":"469","author":"Zhao","year":"2015","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.bbadis.2018.11.017_bb0515","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s13311-013-0208-3","article-title":"Development of inducible leucine-rich repeat kinase 2 (LRRK2) cell lines for therapeutics development in Parkinson's disease","volume":"10","author":"Huang","year":"2013","journal-title":"Neurotherapeutics"},{"issue":"10","key":"10.1016\/j.bbadis.2018.11.017_bb0520","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/nn1776","article-title":"Kinase activity of mutant LRRK2 mediates neuronal toxicity","volume":"9","author":"Smith","year":"2006","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.bbadis.2018.11.017_bb0525","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.nbd.2006.04.001","article-title":"Kinase activity is required for the toxic effects of mutant LRRK2\/dardarin","volume":"23","author":"Greggio","year":"2006","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.bbadis.2018.11.017_bb0530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034693","article-title":"Impaired inflammatory responses in murine Lrrk2-knockdown brain microglia","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"issue":"16 Pt 2","key":"10.1016\/j.bbadis.2018.11.017_bb0535","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1212\/01.wnl.0000304044.22253.03","article-title":"Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease","volume":"70","author":"Haugarvoll","year":"2008","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.bbadis.2018.11.017_bb0540","doi-asserted-by":"crossref","first-page":"2656 e17","DOI":"10.1016\/j.neurobiolaging.2014.05.025","article-title":"Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's disease","volume":"35","author":"Hatano","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"16","key":"10.1016\/j.bbadis.2018.11.017_bb0545","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1016\/j.yexcr.2007.07.007","article-title":"The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity","volume":"313","author":"Guo","year":"2007","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.bbadis.2018.11.017_bb0550","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1096\/fj.15-277095","article-title":"LRRK2 autophosphorylation enhances its GTPase activity","volume":"30","author":"Liu","year":"2016","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.bbadis.2018.11.017_bb0555","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s40478-017-0492-y","article-title":"Elevated LRRK2 autophosphorylation in brain-derived and peripheral exosomes in LRRK2 mutation carriers","volume":"5","author":"Wang","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"issue":"11","key":"10.1016\/j.bbadis.2018.11.017_bb0560","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1073\/pnas.1323285111","article-title":"Parkinson disease-associated mutation R1441H in LRRK2 prolongs the \u201cactive state\u201d of its GTPase domain","volume":"111","author":"Liao","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"46","key":"10.1016\/j.bbadis.2018.11.017_bb0565","doi-asserted-by":"crossref","first-page":"16842","DOI":"10.1073\/pnas.0507360102","article-title":"Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity","volume":"102","author":"West","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"21","key":"10.1016\/j.bbadis.2018.11.017_bb0570","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.1093\/hmg\/ddv314","article-title":"Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression","volume":"24","author":"Henry","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.bbadis.2018.11.017_bb0575","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005949","article-title":"Regulation of LRRK2 stability by the E3 ubiquitin ligase CHIP","volume":"4","author":"Ding","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2018.11.017_bb0580","doi-asserted-by":"crossref","first-page":"11792","DOI":"10.1038\/ncomms11792","article-title":"Ubiqutination via K27 and K29 chains signals aggregation and neuronal protection of LRRK2 by WSB1","volume":"7","author":"Nucifora","year":"2016","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.bbadis.2018.11.017_bb0585","first-page":"4525","article-title":"Dopaminergic innervation of the pallidum in the normal state, in MPTP-treated monkeys and in parkinsonian patients","volume":"12","author":"Jan","year":"2000","journal-title":"Eur. J. Neurosci."},{"issue":"6 Suppl 3","key":"10.1016\/j.bbadis.2018.11.017_bb0590","first-page":"S4","article-title":"The MPTP-treated primate as a model of motor complications in PD: primate model of motor complications","volume":"61","author":"Jenner","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.bbadis.2018.11.017_bb0595","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molbrainres.2004.09.017","article-title":"The MPTP model of Parkinson's disease","volume":"134","author":"Smeyne","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"2","key":"10.1016\/j.bbadis.2018.11.017_bb0600","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1471-4159.2001.00174.x","article-title":"Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease","volume":"76","author":"Przedborski","year":"2001","journal-title":"J. Neurochem."},{"issue":"22","key":"10.1016\/j.bbadis.2018.11.017_bb0605","doi-asserted-by":"crossref","first-page":"14524","DOI":"10.1073\/pnas.172514599","article-title":"Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP","volume":"99","author":"Dauer","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.bbadis.2018.11.017_bb0610","first-page":"916","article-title":"Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis","volume":"15","author":"Lee","year":"2001","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.bbadis.2018.11.017_bb0615","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/toxsci\/kfi304","article-title":"Paraquat neurotoxicity is distinct from that of MPTP and rotenone","volume":"88","author":"Richardson","year":"2005","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.bbadis.2018.11.017_bb0620","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.toxlet.2014.11.029","article-title":"The molecular mechanism of rotenone-induced alpha-synuclein aggregation: emphasizing the role of the calcium\/GSK3beta pathway","volume":"233","author":"Yuan","year":"2015","journal-title":"Toxicol. Lett."},{"issue":"3","key":"10.1016\/j.bbadis.2018.11.017_bb0625","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1007\/s12035-014-8711-z","article-title":"Alpha-synuclein oligomerization in manganese-induced nerve cell injury in brain slices: a role of NO-mediated S-nitrosylation of protein disulfide isomerase","volume":"50","author":"Xu","year":"2014","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.bbadis.2018.11.017_bb0630","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1074\/jbc.C100560200","article-title":"The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein","volume":"277","author":"Manning-Bog","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bbadis.2018.11.017_bb0635","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1523\/JNEUROSCI.23-08-03095.2003","article-title":"Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration","volume":"23","author":"Manning-Bog","year":"2003","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.bbadis.2018.11.017_bb0640","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1039\/C6DT00184J","article-title":"Manganism and Parkinson's disease: Mn(II) and Zn(II) interaction with a 30-amino acid fragment","volume":"45","author":"Remelli","year":"2016","journal-title":"Dalton Trans."},{"key":"10.1016\/j.bbadis.2018.11.017_bb0645","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3389\/fnins.2016.00364","article-title":"Untangling the manganese-alpha-synuclein web","volume":"10","author":"Peres","year":"2016","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.bbadis.2018.11.017_bb0650","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.neuroscience.2004.06.048","article-title":"Proteasomal inhibition induced by manganese ethylene-bis-dithiocarbamate: relevance to Parkinson's disease","volume":"128","author":"Zhou","year":"2004","journal-title":"Neuroscience"},{"issue":"12","key":"10.1016\/j.bbadis.2018.11.017_bb0655","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1073\/pnas.0407881102","article-title":"Structural characterization of copper(II) binding to alpha-synuclein: insights into the bioinorganic chemistry of Parkinson's disease","volume":"102","author":"Rasia","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"30","key":"10.1016\/j.bbadis.2018.11.017_bb0660","doi-asserted-by":"crossref","first-page":"9893","DOI":"10.1021\/ja0618649","article-title":"Interaction of alpha-synuclein with divalent metal ions reveals key differences: a link between structure, binding specificity and fibrillation enhancement","volume":"128","author":"Binolfi","year":"2006","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.bbadis.2018.11.017_bb0665","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5599\/admet.3.1.159","article-title":"Expression and transport of alpha-synuclein at the blood-cerebrospinal fluid barrier and effects of manganese exposure","volume":"3","author":"Bates","year":"2015","journal-title":"ADMET DMPK"},{"issue":"3","key":"10.1016\/j.bbadis.2018.11.017_bb0670","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1039\/C3MT00325F","article-title":"The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of alpha-synuclein in C. elegans","volume":"6","author":"Bornhorst","year":"2014","journal-title":"Metallomics"},{"issue":"29","key":"10.1016\/j.bbadis.2018.11.017_bb0675","doi-asserted-by":"crossref","first-page":"9210","DOI":"10.1523\/JNEUROSCI.2281-09.2009","article-title":"LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans","volume":"29","author":"Saha","year":"2009","journal-title":"J. Neurosci."},{"issue":"36","key":"10.1016\/j.bbadis.2018.11.017_bb0680","doi-asserted-by":"crossref","first-page":"11257","DOI":"10.1523\/JNEUROSCI.2375-09.2009","article-title":"Parkin protects against LRRK2 G2019S mutant-induced dopaminergic neurodegeneration in Drosophila","volume":"29","author":"Ng","year":"2009","journal-title":"J. Neurosci."},{"issue":"50","key":"10.1016\/j.bbadis.2018.11.017_bb0685","doi-asserted-by":"crossref","first-page":"15846","DOI":"10.1523\/JNEUROSCI.4357-09.2009","article-title":"Unexpected lack of hypersensitivity in LRRK2 knock-out mice to MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)","volume":"29","author":"Andres-Mateos","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2018.11.017_bb0690","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1742-2094-11-52","article-title":"LRRK2 and neuroinflammation: partners in crime in Parkinson's disease?","volume":"11","author":"Russo","year":"2014","journal-title":"J. Neuroinflammation"},{"issue":"8","key":"10.1016\/j.bbadis.2018.11.017_bb0695","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.bjp.0707167","article-title":"Inflammation as a causative factor in the aetiology of Parkinson's disease","volume":"150","author":"Whitton","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbadis.2018.11.017_bb0700","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1523\/JNEUROSCI.5175-08.2009","article-title":"The Parkinson disease protein leucine-rich repeat kinase 2 transduces death signals via Fas-associated protein with death domain and caspase-8 in a cellular model of neurodegeneration","volume":"29","author":"Ho","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2018.11.017_bb0705","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-3-319-60189-2_8","article-title":"Inflammatory activation of microglia and astrocytes in manganese neurotoxicity","volume":"18","author":"Tjalkens","year":"2017","journal-title":"Adv. Neurobiol."},{"issue":"14","key":"10.1016\/j.bbadis.2018.11.017_bb0710","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1021\/bi901726c","article-title":"Differential effects of divalent manganese and magnesium on the kinase activity of leucine-rich repeat kinase 2 (LRRK2)","volume":"49","author":"Lovitt","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2018.11.017_bb0715","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neuro.2013.04.008","article-title":"Down-regulation of LRRK2 in control and DAT transfected HEK cells increases manganese-induced oxidative stress and cell toxicity","volume":"37","author":"Roth","year":"2013","journal-title":"Neurotoxicology"},{"issue":"9","key":"10.1016\/j.bbadis.2018.11.017_bb0720","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4103\/1947-2714.100998","article-title":"Western blot: technique, theory, and trouble shooting","volume":"4","author":"Mahmood","year":"2012","journal-title":"N. Am. J. Med. Sci."},{"issue":"3","key":"10.1016\/j.bbadis.2018.11.017_bb0725","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1586\/14789450.2015.1042867","article-title":"Current strategies and findings in clinically relevant post-translational modification-specific proteomics","volume":"12","author":"Pagel","year":"2015","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.bbadis.2018.11.017_bb0730","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12813","article-title":"Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases","volume":"5","author":"Steger","year":"2016","journal-title":"elife"},{"key":"10.1016\/j.bbadis.2018.11.017_bb0735","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.778","article-title":"Computational analysis of the LRRK2 interactome","volume":"3","author":"Manzoni","year":"2015","journal-title":"PeerJ"},{"issue":"1","key":"10.1016\/j.bbadis.2018.11.017_bb0740","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1038\/s41467-017-01808-6","article-title":"Quantitative analysis of protein-protein interactions and post-translational modifications in rare immune populations","volume":"8","author":"Avin","year":"2017","journal-title":"Nat. Commun."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443918304782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443918304782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T05:38:36Z","timestamp":1775281116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443918304782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":148,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0925443918304782"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2018.11.017","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of posttranslational modifications of \u03b1-synuclein and LRRK2 in Parkinson's disease: Potential contributions of environmental factors","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2018.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}